BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11290779)

  • 21. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
    Lowin-Kropf B; Kunz B; Schneider P; Held W
    Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Ly-49D receptor activates murine natural killer cells.
    Mason LH; Anderson SK; Yokoyama WM; Smith HR; Winkler-Pickett R; Ortaldo JR
    J Exp Med; 1996 Dec; 184(6):2119-28. PubMed ID: 8976168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
    Tassi I; Presti R; Kim S; Yokoyama WM; Gilfillan S; Colonna M
    J Immunol; 2005 Jul; 175(2):749-54. PubMed ID: 16002670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
    Nakamura MC; Linnemeyer PA; Niemi EC; Mason LH; Ortaldo JR; Ryan JC; Seaman WE
    J Exp Med; 1999 Feb; 189(3):493-500. PubMed ID: 9927511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
    Huntington ND; Xu Y; Nutt SL; Tarlinton DM
    J Exp Med; 2005 May; 201(9):1421-33. PubMed ID: 15867094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing.
    Idris AH; Smith HR; Mason LH; Ortaldo JR; Scalzo AA; Yokoyama WM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6330-5. PubMed ID: 10339587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ly-49 receptor expression and functional analysis in multiple mouse strains.
    Ortaldo JR; Mason AT; Winkler-Pickett R; Raziuddin A; Murphy WJ; Mason LH
    J Leukoc Biol; 1999 Sep; 66(3):512-20. PubMed ID: 10496323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse Ly49 NK receptors: balancing activation and inhibition.
    Ortaldo JR; Young HA
    Mol Immunol; 2005 Feb; 42(4):445-50. PubMed ID: 15607796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands.
    Naper C; Hayashi S; Kveberg L; Niemi EC; Lanier LL; Vaage JT; Ryan JC
    J Immunol; 2002 Jul; 169(1):22-30. PubMed ID: 12077224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
    Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
    J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of NK cells with reduction of their inhibitory Ly-49A, Ly-49C, and Ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control.
    Korten S; Volkmann L; Saeftel M; Fischer K; Taniguchi M; Fleischer B; Hoerauf A
    J Immunol; 2002 May; 168(10):5199-206. PubMed ID: 11994476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d).
    Nakamura MC; Hayashi S; Niemi EC; Ryan JC; Seaman WE
    J Exp Med; 2000 Aug; 192(3):447-54. PubMed ID: 10934233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d).
    Silver ET; Gong D; Hazes B; Kane KP
    J Immunol; 2001 Feb; 166(4):2333-41. PubMed ID: 11160290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class I MHC-binding characteristics of the 129/J Ly49 repertoire.
    Makrigiannis AP; Pau AT; Saleh A; Winkler-Pickett R; Ortaldo JR; Anderson SK
    J Immunol; 2001 Apr; 166(8):5034-43. PubMed ID: 11290784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation.
    Colucci F; Turner M; Schweighoffer E; Guy-Grand D; Di Bartolo V; Salcedo M; Tybulewicz VL; Di Santo JP
    J Immunol; 1999 Aug; 163(4):1769-74. PubMed ID: 10438908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.